Flu 2024 Treatment Resistant. Oseltamivir ranks as the most commonly prescribed. A rare flu variant that has shown some resistance to the most commonly used antiviral treatment has been detected in at least two people in the united states, according to the us centers for.
On september 20, 2024, the food and drug administration (fda) approved the nasal spray flu vaccine, flumist, for self or caregiver administration. Issues related to treatment of seasonal influenza will be reviewed here.